Click a link below to view the mailing archive as if it had been sent to you.
| 2021-12-31 12:15 | | Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers and more... |
| 2021-12-31 00:15 | | Teva suffers trial loss in New York's landmark opioid case and more... |
| 2021-12-30 12:15 | | To buy or not to buy? Samsung unit denies report about Biogen talks and more... |
| 2021-12-30 00:15 | | Biogen surges on potential buyout deal from South Korea's Samsung Group |
| 2021-12-29 12:15 | | Bayer Commits to 100 Percent Green Packaging by 2030 and more... |
| 2021-12-28 12:15 | | 2022 forecast: Pharma has the tools. Will clinical trials be less white in next year? and more... |
| 2021-12-27 12:15 | | Key data reveals for the small players and more... |
| 2021-12-27 00:15 | | FDA approves Novartis’ Cosentyx to treat arthritis in children and adolescents and more... |
| 2021-12-24 00:15 | | FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited and more... |
| 2021-12-23 12:15 | | FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag |
| 2021-12-23 00:15 | | Novavax says COVID vaccine triggers immune response to Omicron variant and more... |
| 2021-12-22 12:15 | | Amgen builds Otezla’s psoriasis label as rival BMS looms large and more... |
| 2021-12-21 12:15 | | Sanofi buys US immuno-oncology biotech Amunix for $1 billion and more... |
| 2021-12-21 00:15 | | Omicron variant now makes up 73% of Covid infections diagnosed in U.S. and more... |
| 2021-12-20 12:15 | | Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears and more... |
| 2021-12-19 00:15 | | Biotech startup lines up more cash to steer its NASH drug through stormy seas and more... |
| 2021-12-17 12:15 | | FDA delays its decision on Bristol Myers' $13B heart drug another three months and more... |
| 2021-12-17 00:15 | | Closing Arguments Begin in the Trial of Elizabeth Holmes and more... |
| 2021-12-16 12:15 | | Medtronic hit with FDA warning letter for diabetes devices and more... |
| 2021-12-16 00:15 | | Bristol Myers drug wins first U.S. approval for Graft versus Host Disease prevention and more... |
| 2021-12-15 12:15 | | Bowing to pressure, J.P. Morgan says its health care conference will be virtual and more... |
| 2021-12-15 00:15 | | Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns and more... |
| 2021-12-14 12:15 | | Efficacy of Pfizer's Covid pill holds up in final analysis, reducing risk of hospitalization or death by almost 90% and more... |
| 2021-12-14 00:15 | | Merck’s Covid Pill Might Pose Risks for Pregnant Women and more... |
| 2021-12-13 12:15 | | Arena, completing its turnaround, sells to Pfizer for nearly $7 billion and more... |
| 2021-12-13 00:15 | | Young CEO’s Company Reinvents How Eyedrops Are Delivered and more... |
| 2021-12-12 00:15 | | Three More Biopharma Expansions to Round Out the Week and more... |
| 2021-12-11 00:15 | | Moderna agrees up to 150 million extra vaccine doses for COVAX |
| 2021-12-10 12:15 | | Eli Lilly pens $1.5B biobucks pact with China's Regor for metabolic disease work and more... |
| 2021-12-10 00:15 | | Four Fresh-Faced Biopharmas Reel in Millions in Series A Funds |
| 2021-12-09 12:15 | | Novartis works on pan-coronavirus pill, eyes 2022 human testing and more... |
| 2021-12-09 00:15 | | Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout and more... |
| 2021-12-08 12:15 | | For pharmas dealing with HCPs, the future is in a hybrid two-phase model and more... |
| 2021-12-08 00:15 | | A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants and more... |
| 2021-12-07 12:15 | | New data shows GSK-Vir drug works against all Omicron mutations and more... |
| 2021-12-07 00:15 | | Large Study Indicates Viagra Might Reduce Alzheimer's Risk and more... |
| 2021-12-06 12:15 | | Keytruda wins eighth FDA approval of 2021, moving into adjuvant and pediatric melanoma settings and more... |
| 2021-12-06 00:15 | | Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way? and more... |
| 2021-12-03 12:15 | | Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines and more... |
| 2021-12-03 00:15 | | Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’ and more... |
| 2021-12-02 12:15 | | A Seattle biotech offloads lead eye drug in deal valued at $1B+ as it refocuses on emerging pipeline and more... |
| 2021-12-02 00:15 | | Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta and more... |
| 2021-12-01 12:15 | | Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says and more... |
| 2021-12-01 00:15 | | Biogen takes another blow as appeal for Tecfidera patent revival falls short and more... |
